Publicaciones en colaboración con investigadores/as de Hospital de Cruces (9)

2008

  1. Prognostic factors in cancer of unknown primary site

    Clinical and Translational Oncology

2007

  1. Reversible liver toxicity with adjuvant trastuzumab for localized breast cancer [5]

    Annals of Oncology

2005

  1. High-dose interleukin-2 in metastatic renal cell carcinoma [3]

    Journal of Clinical Oncology

2004

  1. Factores pronósticos y predictivos en pacientes con cáncer de origen desconocido tratados con un esquema de quimioterapia con paclitaxel

    Medicina Clinica, Vol. 122, Núm. 6, pp. 216-218

  2. Preradiation chemotherapy with VM-26 and CCNU in patients with glioblastoma multiforme

    Tumori, Vol. 90, Núm. 6, pp. 562-566

2003

  1. A novel biweekly schedule with cisplatin and gemcitabine in advanced non-small cell lung cancer

    International Journal of Clinical Pharmacology Research, Vol. 23, Núm. 1, pp. 9-16

  2. Onycholysis associated with capecitabine in combination with irinotecan in two patients with colorectal cancer [3]

    Journal of the National Cancer Institute

2002

  1. Phase II study of docetaxel/vinorelbine in patients with non-small-cell-lung cancer previously treated with platinum-based chemotherapy

    Clinical Lung Cancer, Vol. 4, Núm. 3, pp. 168-173

2000

  1. Indicaciones de quimioterapia en cáncer de mama

    Gaceta médica de Bilbao: Revista oficial de la Academia de Ciencias Médicas de Bilbao. Información para profesionales sanitarios, Vol. 97, Núm. 4, pp. 105-114